Clinical approach to lithium development

Higher voltage cathodes in lithium-ion batteries mean higher performance systems. But how can they be produced rapidly for evaluation? Gerry Woolf learned from Wildcat Technologies how the company is bringing this about in the lithium-ion industry.

There's a lot the battery industry could learn from the pharmaceutical industry. The first thing a drug company has to have is a huge portfolio of drugs in development to keep investors happy because pharmaceutical patents have short lives. Today's winner is tomorrow's generic. The second thing a pharmaceutical company needs is a means of evaluating . . .